Frank Litvack

CIK 1310715 · CEO and Chairman · last filed 2026-05-14

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$4.65M

Companies

4

Total Filings

24

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CAPR Director 180,054 $25.80 $4.65M $0 18 2026-05-14
CAPRICOR THERAPEUTICS, INC. (NLTXW) Delisted Director 200,000 $0 2 2011-05-12
CAPRICOR THERAPEUTICS, INC. (NLTX) Delisted Director 200,000 $13.96 $2.79M $0 1 2009-09-28
CONOR MEDSYSTEMS INC (CONR) Delisted CEO and Chairman 0 $0 2 2007-02-02

Recent Filings · Page 2 of 3

24 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-01-06 CAPR Grant (A) $0 EDGAR
2020-06-09 CAPR Grant (A) $0 EDGAR
2020-02-14 CAPR Mixed $0 EDGAR
2019-12-19 CAPR Grant (A) +20,391 $0 EDGAR
2019-08-09 CAPR Grant (A) $0 EDGAR
2018-01-04 CAPR Grant (A) $0 EDGAR
2017-01-04 CAPR Grant (A) $0 EDGAR
2016-06-06 CAPR Grant (A) $0 EDGAR
2015-03-05 Grant (A) $0
2011-05-12 CAPRICOR THERAPEUTICS, INC. (NLTXW) Delisted Grant (A) $0 EDGAR
Showing 1120 of 24
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.